WormMine: Gene WBGene00005556

• WormBase Gene ID: WBGene00005556
• Gene Name: sri-44
• Sequence Name: K07E8.12
• Organism: Caenorhabditis elegans
• Automated Description: Enriched in Q cell based on RNA-seq studies. Is affected by several genes including etr-1; cnd-1; and adr-1 based on RNA-seq studies. Is affected by six chemicals including Psoralens; allantoin; and metformin based on RNA-seq studies.
• Biotype: SO:0000336
• Genetic Position: II :-15.5919 ±0.000131
• Length (nt): 2303

1 Organism

• Name: Caenorhabditis elegans
• Taxon Id: 6239

1 Synonyms

• Value: WBGene00005556

Genomics

0 Transcripts

Other

0 CDSs

0 RNAi Result

76 Allele

• gk964317
• gk963801
• gk132104
• gk132105
• WBVar01715576
• WBVar01715575
• gk953950
• gk963562
• gk963563
• tm11237
• gk469174
• WBVar01238095
• gk848234
• gk716806
• gk449428
• gk532650
• gk929741
• gk836806
• WBVar01574621
• gk441321
• gk441322
• gk513568
• gk592069
• gk607538
• gk593143
• gk773499
• gk908434
• WBVar01705008
• WBVar01988667
• gk1722

1 Chromosome

• WormBase ID: II
• Organism: Caenorhabditis elegans
• Length (nt): 15279421

1 Chromosome Location

• Feature . Primary Identifier: WBGene00005556
• Start: 671542
• End: 673844
• Strand: -1

2 Data Sets

• WormBaseAcedbConverter
• C. elegans genomic annotations (GFF3 Gene)

1 Downstream Intergenic Region

• WormBase ID: intergenic_region_chrII_671126..671541
• Length (nt): 416
• Chromosome Location: II: 671126-671541
• Organism: Caenorhabditis elegans

16 Expression Clusters

Regulated By Treatment	Description	Algorithm	Primary Identifier
	Transcripts that showed significantly increased expression after animals were treated with 50uM Rifampicin and 250uM Allantoin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Rifampicin-Allantoin_upregulated
	Transcripts that showed significantly increased expression after animals were treated with 50uM Rifampicin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Rifampicin_upregulated
	Transcripts that showed significantly increased expression after animals were treated with 100uM Psora and 250uM Allantoin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Psora-Allantoin_upregulated
	Transcripts that showed significantly increased expression after animals were treated with 100uM Rapamycin and 50mM Metformin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Rapamycin-Metformin_upregulated
	Transcripts that showed altered expression in cat-1(RNAi) animals comparing to control animals injected with empty vector.	p-value <= 0.05	WBPaper00066902:cat-1(RNAi)_regulated
	Transcripts that showed significantly decreased expression in eat-2(ad1116) comparing to in N2 at 3-days post L4 adult hermaphrodite animals.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:eat-2(ad1116)_downregulated
	Transcripts that showed significantly decreased expression after animals were treated with 100uM Rapamycin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Rapamycin_downregulated
	Transcripts enriched in Q cell.	DESeq2 (version 2.11.40.7) FDR < 0.05, fold change > 2.	WBPaper00066652:Q-cell_enriched
Bacteria Diet: L. plantarum with pdxH mutant vs. L. plantarum	Transcripts that showed significantly decreased expression in N2 animals fed with L. plantarum with pdxH mutant, comparing to in N2 animals fed with L. plantarum.	GFold3, logFC < -1 or > 1.	WBPaper00066703:L.plantarum-pdxH_downregulated
	Transcripts that showed significantly increased expression after animals were treated with 100uM Rapamycin, 50uM Rifampicin and 250uM Allantoin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Rapamycin-Rifampicin-Allantoin_upregulated
	Transcripts that showed significantly increased expression after animals were treated with 100uM Rapamycin and 50uM Rifampicin from day 1 to day 3 adult hermaphradite.	DESeq2(v1.14.1), fold change > 2, p-value < 0.05	WBPaper00055354:Rapamycin-Rifampicin_upregulated
	Transcripts that showed significantly decreased expression after 24 hours of treatment by 50 uM atracurium.	Differential expression was assessed using an empirical Bayes moderated t test within limma's linear model framework including the precision weights estimated by voom. Resulting p-values were corrected for multiple testing using the Benjamini-Hochberg false discovery rate. Fold change > 2, p-value < 0.05.	WBPaper00061636:atracurium_downregulated
	Transcripts that showed significantly increased expression in adr-1(tm668) comparing to in N2.	DESeq2, p-value < 0.05 and a fold enrichment log2fold > 0.5.	WBPaper00055226:adr-1(tm668)_upregulated
	Transcripts that showed significantly decreased expression after animals were exposed to 500 uM of 3-dihydro-2-phenyl-sulfanylenebenzo[d] [1,3,2]-oxazaphosphole (FW1256) from L1 stage larvae onwards.	The DESeq2 package (v1.24.0) was used to identify differentially expressed genes (DEGs). Fold change > 2, FDR < 0.05.	WBPaper00061040:FW1256_downregulated
	Transcripts of noncoding genes that showed significantly decreased expression in muscle.	DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed.	WBPaper00062325:muscle_depleted_noncoding-RNA
	Transcripts that showed significantly decreased expression in cnd-1(ju29) comparing to in N2.	DESeq2 1.16.1 (R3.4.1)	WBPaper00059932:cnd-1(ju29)_downregulated

0 Expression Patterns

0 GO Annotation

0 Homologues

1 Locations

• Feature . Primary Identifier: WBGene00005556
• Start: 671542
• End: 673844
• Strand: -1

0 Ontology Annotations

0 Regulates Expr Cluster

1 Sequence

• Length: 2303

1 Sequence Ontology Term